Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00023205
Status:
COMPLETED
Last Update Posted:
2013-12-24
First Post:
2001-08-29
Brief Title:
Impact of Literacy Level on Patient Education and Health Among People With Arthritis
Sponsor:
Brigham and Womens Hospital
Organization:
Brigham and Womens Hospital
Study Overview
Official Title:
Literacy in Arthritis Management A Randomized Controlled Clinical Trial of a Novel Education Intervention
Status:
COMPLETED
Status Verified Date:
2013-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
People with poor literacy may have worse health and less knowledge about how to manage their disease than patients at high reading levels Patients with arthritis usually receive information on how to manage their disease that is written at an 11th grade reading level The purpose of this study is to compare the health outcomes of patients with arthritis given either standard 11th grade level materials or interactive in-person arthritis education along with materials written at a lower reading level
Detailed Description:
Patients with poor literacy report worse health and know less about managing their disease than patients with better literacy This study will compare the disease outcomes of arthritis patients at three different reading levels who receive either standard arthritis materials written at an 11th grade reading level or an in-person interactive text-free session along with lower reading level materials The study will determine the most effective methods of educating patients with poor literacy about their disease
Patients with systemic inflammatory rheumatic conditions rheumatoid arthritis psoriatic arthritis and seronegative polyarthritis will be assessed and placed into one of three reading levels 8th grade or lower 9th to 11th grade or 12th grade or higher Patients from each reading level will be randomly assigned to one of two intervention groups Group 1 will receive disease-specific material from the Arthritis Foundation written at an 11th grade reading level Group 2 will receive plain language materials an arthritis glossary and a one-hour in-person session with a study educator using interactive text-free methods The study educator will help the patient with reading-related problems either by study visit or by telephone for 6 months postsession
All patients will receive a medication calendar Patients will be followed for one year after the intervention and will be assessed for changes in health status disease activity communication with the physician self-management of their arthritis understanding of and adherence to prescribed treatment and satisfaction with their intervention
Patients with systemic inflammatory rheumatic conditions rheumatoid arthritis psoriatic arthritis and seronegative polyarthritis will be assessed and placed into one of three reading levels 8th grade or lower 9th to 11th grade or 12th grade or higher Patients from each reading level will be randomly assigned to one of two intervention groups Group 1 will receive disease-specific material from the Arthritis Foundation written at an 11th grade reading level Group 2 will receive plain language materials an arthritis glossary and a one-hour in-person session with a study educator using interactive text-free methods The study educator will help the patient with reading-related problems either by study visit or by telephone for 6 months postsession
All patients will receive a medication calendar Patients will be followed for one year after the intervention and will be assessed for changes in health status disease activity communication with the physician self-management of their arthritis understanding of and adherence to prescribed treatment and satisfaction with their intervention
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| P60AR047782 | NIH | None | httpsreporternihgovquickSearchP60AR047782 |